This mechanistic finding linking PRMT5 to HR and HR to TMZ resistance provides a novel insight and potential solution to overcome TMZ resistance in glioblastoma because, in the combination treatment, as PRMT5 inhibition severely affects the HR repair pathway (Fig. 5), it sensitizes GBMNS to TMZ treatment. This evidence concerns the gene PRMT5 and glioblastoma.